Long-awaited cystic fibrosis drug could turn deadly disease into a manageable condition

Meghan McGarry, a pulmonologist at the University of California at San Francisco, recently completed a study that examined Puerto Rican and Dominican patients and found that their diseases were driven by rare mutations.
Eric Anderson

Web design and development since Y2K. Squarespace insider, and expert level website builder.

https://www.weekofthewebsite.com
Previous
Previous

Latinos on 2 Caribbean Islands Carry CFTR Mutations Seen in 1% of CF Patients Elsewhere, Study Says

Next
Next

Rare Cystic Fibrosis Mutations Dominate in Caribbean Patients